JRNYS

1. 3. Cancel through the dashboard or support at least seven days before the next billing cycle. The cancellation page promises prorating with longer notice, while terms contain competing bracketed prorating/nonrefund clauses. Initial reviewed telehealth fee is listed as $89 in cancellation policy and $35 in terms; amount and additional-fee status remain unresolved. Shipped medical products cannot be returned. Appointment cancellation within 24 hours or a no-show can incur $25. https://jrnys.com/cancellation-policy https://jrnys.com/terms-and-conditions
2. 4. The $25 figure is a general insurance estimate, not a selected Ozempic/Wegovy or Mounjaro/Zepbound invoice. No cash drug invoice is established. https://jrnys.com/weight-loss/product/ozempic
3. 5. The $25 figure is a general insurance estimate, not a selected Ozempic/Wegovy or Mounjaro/Zepbound invoice. No cash drug invoice is established. https://jrnys.com/weight-loss/product/mounjaro
4. 6. The named compounded tirzepatide microdose remains publicly listed from $216/m. The product page does not establish whether the separate $89–$169 membership applies or is included, so the former universal additional-membership assumption is not repeated. No exact device or dispensed quantity is established. https://jrnys.com/weight-loss/product/tirzepatide-microdose
5. 7. The campaign separately links a standard compounded tirzepatide page without a price or exact delivery form. It is recorded as additional catalog scope of this ingredient record; the microdose price is not assigned to the standard offer. https://jrnys.com/weight-loss/product/tirzepatide
6. 8. A dedicated commercial page explicitly names compounded semaglutide from $199/month, separately from membership. The Wegovy-page FAQ explicitly describes the compounded treatment as a weekly injection; a product image is not treated as proof of a specific vial/device. https://jrnys.com/weight-loss/product/compounded-semaglutide-2 https://jrnys.com/weight-loss/product/wegovvy
7. 9. JRNYS names liraglutide among the medications its doctors may prescribe through its monthly program, after reviewing medical history and treatment goals. The prescribing menu does not identify a selected brand, administration route, dose or dispensing device for this ingredient. https://jrnys.com/weight-loss/product/ozempic
8. 10. No liraglutide-specific medication price, initial payment or renewal amount is established by the prescribing menu. Prices and care fees shown for other medicines are not a quote for this option. Confirm the selected medication and all charges before paying. https://jrnys.com/weight-loss/product/ozempic
9. 11. The reviewed pages do not establish which pharmacy, state eligibility, consultation format, separate care charges or cancellation terms apply to a selected liraglutide prescription. General service terms describe consultation and cancellation options, but their application to this particular option remains unconfirmed. https://jrnys.com/terms-and-conditions https://jrnys.com/cancellation-policy
10. 12. JRNYS names dulaglutide among the medications its doctors may prescribe through its monthly program, after reviewing medical history and treatment goals. The prescribing menu does not identify a selected brand, administration route, dose or dispensing device for this ingredient. https://jrnys.com/weight-loss/product/ozempic
11. 13. No dulaglutide-specific medication price, initial payment or renewal amount is established by the prescribing menu. Prices and care fees shown for other medicines are not a quote for this option. Confirm the selected medication and all charges before paying. https://jrnys.com/weight-loss/product/ozempic
12. 14. The reviewed pages do not establish which pharmacy, state eligibility, consultation format, separate care charges or cancellation terms apply to a selected dulaglutide prescription. General service terms describe consultation and cancellation options, but their application to this particular option remains unconfirmed. https://jrnys.com/terms-and-conditions https://jrnys.com/cancellation-policy

September 2026

1. 15. Textbook membership trap: the headline '$89/month' figure repeated across the whole site is explicitly footnoted '*Does not include the cost of medication' and confirmed on product pages as a $89-$169/mo membership fee only. JRNYS sells brand-name GLP-1s (Ozempic, Mounjaro, Zepbound, Wegovy) via insurance navigation, for which the only price given is an insurance-capped '$25 per month after any deductible is met' (an insurance price, recorded separately per the brief's rule) — no cash price for the brand path is published. Separately, JRNYS also sells a 'Compounded Tirzepatide Microdose' product at a flat 'from $216/m' cash price, framed as inclusive ('Compounded medications are not FDA-approved... prepared by licensed pharmacies'); this is NOT the same product as the branded Mounjaro/Zepbound path and is recorded as its own entry. Also found a real self-contradiction: the Cancellation Policy page says 'your initial telehealth fee of $89 will not be refunded,' while the Terms & Conditions page says 'your initial telehealth fee of $35 will not be refunded' for the same fee — flagged, not resolved. No page stating served states was found. Footer legal text names a 'KINSYN' brand ('KINSYN provides clinician-guided wellness and metabolic health programs') alongside JRNYS, suggesting a shared backend across brands.